Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,119 public trials 2,034 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Completed

S1001 PET-Directed Therapy in Treating Patients With Limited-Stage Diffuse Large B-Cell Lymphoma

NCT01359592

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Providence Cancer Center Anchorage, Alaska, United States
  • Arizona Cancer Center at University of Arizona Health Sciences Center Tucson, Arizona, United States
  • Aurora Presbyterian Hospital Aurora, Colorado, United States
  • Boulder Community Hospital Boulder, Colorado, United States
View all 240 locations
View Trial Details
Completed

ALL Adult Consortium Trial: Adult ALL Trial

NCT00476190

Conditions
Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Children's Hospital of Boston Boston, Massachusetts, United States
  • Beth Isreal Deaconess Medical Center Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View all 15 locations
View Trial Details
Completed

Bardoxolone Methyl Evaluation in Patients With Pulmonary Hypertension (PH) - LARIAT

NCT02036970

Conditions
Acute Interstitial Pneumonitis, Bronchial Diseases, Bronchiolitis, +32 more
Locations
  • Banner University Medical Center, Phoenix Advanced Lung Disease Institute Phoenix, Arizona, United States
  • Arizona Pulmonary Specialists Phoenix, Arizona, United States
  • Cedars Sinai Medical Center Beverly Hills, California, United States
  • VA Healthcare System of Greater Los Angeles Los Angeles, California, United States
View all 32 locations
View Trial Details
Completed

A Study to Assess Safety and Target Engagement of E2814 in Participants With Mild to Moderate Cognitive Impairment Due to Dominantly Inherited Alzheimer's Disease

NCT04971733

Conditions
Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +16 more
Locations
  • UC San Diego Altman Clinical and Translational Research Insititute Clinic La Jolla, California, United States
  • Indiana University School of Medicine, Health Partners, Adult Neurology Clinic Indianapolis, Indiana, United States
  • National Hospital for Neurology and Neurosurgery (NHNN) University College London(UCL) Hospitals NHS Foundation Trust London, United Kingdom
View Trial Details

Related conditions